FDA recall, , Moderate risk
Medtronic Vanta Clinician Programmer Application
The A71200 Vanta Clinician Programmer Application may not function as intended, potentially causing a prolonged or postponed surgical procedure.
Summary by Recall Canary from the FDA notice
What happened
Medtronic Neuromodulation of Minneapolis, Minnesota began a recall of the A71200 Vanta Clinician Programmer Application (CP App) versions 2.0.2465 and 2.0.2683, product number A71200, on December 3, 2025.
The software, deployed and operated on Samsung tablets (CFN CT900), received complaints that it does not function as intended during use, potentially leading to prolonged or postponed surgical procedures. The recall was added to the FDA's Enforcement Report on January 9, 2026, with nationwide distribution in the US and worldwide.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:
- A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
- Talk to your health care provider before you stop using it.
Is yours affected?
Affected if its UDI-DI matches.
A UDI-DI is the device identifier printed with the barcode on the device label.
A71200 Vanta" Clinician Programmer Application (CP App) version 2.0.2465 and 2.0.2683, Product number A71200. Software is deployed and operated on Samsung tablets (CFN CT900).
- UDI-DI
- 00763000520083
Recall details
- Company began the recall
- Sold in
Worldwide - US Nationwide distribution.
- Company
- Medtronic NeuromodulationMinneapolis, Minnesota
- Hazard
- Device defect
- Risk
Moderate risk
Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 98097
- Recall number
- Z-1043-2026
All recalls from Medtronic Neuromodulation
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA
In FDA's weekly enforcement report
Listed on Recall Canary
